Developer docs
API playgroundTry for free, no card

Search company profiles

Canadian Cancer Society

Full company profile

uuid00024iu

Namestring
Canadian Cancer Society
Legal namestring
Canadian Cancer Society
Websiteurl
cancer.ca#
Company typeenum
Private
Founded yearint
1938
Descriptiontext

The Canadian Cancer Society (CCS), founded in 1938 and headquartered in Toronto, is Canada's oldest and largest national cancer charity, registered as charity number 118829803 RR 0001. It operates four interlocking functions: cancer research funding (investing $50.8M in research and innovation in 2024-2025 alone and co-leading a $25M multi-partner clinical trials consortium with the Terry Fox Research Institute, Cancer Research Society, and others); direct patient support services delivered through 12+ regional offices and lodging houses (76,000+ patient nights annually), transportation programs (Wheels of Hope, Air Daffodil, Treatment Transport Fund), and toll-free helplines; cancer information and prevention programs (content covering 100+ cancer types, the It's My Life! youth program, Talk Tobacco Helpline, and the Indigenous-led Connect to Change cessation program); and public-policy advocacy credited with 67 health policy victories. Its service portfolio increasingly includes digital products such as Cancer Trials Canada (a bilingual clinical-trial portal launched with Q-CROC) and AskEllyn, an AI-powered storytelling companion for breast cancer patients.

CCS is a registered nonprofit with no shareholders; its operating budget is funded through individual donations, corporate partnerships (CIBC as Visionary Partner, alongside Desjardins, Kruger Products, and WestJet), planned/legacy giving, community fundraising events (Daffodil Month, Soccer for Cancer), and government/research grants (including over $41M from the Government of Canada for cancer prevention research). It serves five primary stakeholder groups: cancer patients and survivors, caregivers and family members, healthcare professionals, cancer researchers (as grantees), and donors/supporters, with deliberate outreach to Indigenous peoples and underserved communities through equity-focused programs. Headcount is reported in the 5,001-10,000 range, consistent with a national footprint spanning all provinces and operating bilingual (English/French) service delivery.

Technically, CCS is not a technology company; its core platform is a service-delivery and research-funding organization. Its technology footprint centers on the cancer.ca web platform (bilingual), social media channels across six platforms (LinkedIn, Facebook, Instagram, TikTok, YouTube, Bluesky), the Cancer Trials Canada portal, and the AskEllyn AI companion. CCS has begun adopting AI governance frameworks for ethical data use and complies with the CSA Model Code for the Protection of Personal Information (CAN/CSA-Q830-96) and Ontario's AODA (Regulation 191/11). The organization's strategic direction, evidenced by recent launches, is to consolidate its position as Canada's national convener in cancer research, expand digital health tooling, and broaden health-equity reach into Indigenous and underserved populations.

Short descriptiontext

The Canadian Cancer Society, founded in 1938, is Canada's largest national cancer charity, funding research, providing patient support and lodging, delivering cancer information, and advocating for cancer-related public policy across all provinces. It serves patients, caregivers, researchers, donors, and underserved communities through a bilingual nationwide network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices13 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer research funding, cancer support services, patient lodging accommodations, cancer prevention programs, health charity fundraising
Industry3 codes
1Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryYes
2Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryNo
3Global Health Research, Evidence & Technical Assistance Organizations
CodeHLAJAKANPrimaryNo
NAICS code3 codes
  • Voluntary Health Organizations813212
  • Grantmaking and Giving Services81321
  • Social Advocacy Organizations8133
SIC code2 codes
  • Services-Social Services8300
  • Services-Commercial Physical & Biological Research8731
Product category
Cancer Charity and Patient Support Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Individual Donations
TypeGrants Donations
Description

The primary revenue stream comes from individual donors who make personal donations through the CCS website, phone, or mail. Donations support cancer research, patient support services, and advocacy efforts.

cancer.ca
2Corporate Partnerships and Sponsorships
TypeGrants Donations
Description

Corporate partners including CIBC (Visionary Partner), Desjardins, Kruger, and WestJet provide financial support, sponsorships, and in-kind contributions through fundraising events and campaigns.

cancer.ca
3Daffodil Month Campaign
TypeGrants Donations
Description

Annual flagship fundraising campaign held each April, with matching funds available for a portion of the campaign period to accelerate progress and improve survival rates.

newswire.ca
4Soccer for Cancer Program
TypeGrants Donations
Description

National fundraising program enabling soccer players and communities to organize and host cancer fundraising events at community pitches, training facilities, and tournament fields.

newswire.ca
5Planned and Leadership Giving
TypeGrants Donations
Description

Bequests, legacy gifts, and major donor programs for significant contributions supporting long-term cancer research and support initiatives.

cancer.ca
6Government and Research Grants
TypeGrants Donations
Description

CCS partners with government agencies (Government of Canada invested over $41 million in cancer prevention research) and co-funds research initiatives with other foundations.

canada.ca
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

The Canadian Cancer Society funds cancer research through grants and multi-partner coalitions, delivers nationwide cancer information covering more than 100 cancer types, and operates direct patient support services including lodging houses, volunteer transportation, and tobacco cessation helplines. It also runs national fundraising campaigns (Daffodil Month, Soccer for Cancer) and advocacy programs such as the Pan-Canadian Lung Cancer Action Plan.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 18.3 million people supported with cancer information
+4 more records
Product overview1 text field

The Canadian Cancer Society offers a comprehensive portfolio of cancer-related products and services spanning digital platforms, support services, prevention programs, and research initiatives. Key digital offerings include Cancer Trials Canada (a bilingual clinical trial portal), AskEllyn (an AI-powered storytelling companion for breast cancer patients), and the It's My Life! prevention program. Support services include nationwide lodging facilities, transportation programs (Wheels of Hope, Air Daffodil, Treatment Transport Fund), the Talk Tobacco Helpline, and the Connect to Change Indigenous tobacco cessation program. Fundraising initiatives include the annual Daffodil Month campaign and the newly launched Soccer for Cancer program. The Society also drives advocacy through the Pan-Canadian Lung Cancer Action Plan and funds clinical research through partnerships with institutions including the Terry Fox Research Institute.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-22
Description

$25 million multi-partner investment to support investigator-initiated clinical trials across Canada focused on rare, underserved, and low-survival cancers. Also involves Terry Fox Research Institute and multiple other cancer research funders.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-22
Description

Partner in $25 million national program to support independent clinical trials for rare, underserved, and low-survival cancers. Brings together major cancer research funders.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-04-22
Description

Partner contributing pediatric cancer expertise and research infrastructure to the national clinical trials program.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-04-22
Description

Partner in the national clinical trials program focused on childhood and adolescent cancers.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-04-22
Description

Partner bringing immunotherapy and biotherapeutics expertise to the national clinical trials initiative.

6Institut du cancer de Montréal
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-04-22
Description

Partner contributing Montreal-based cancer research expertise to the national clinical trials program.

finance.yahoo.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-10
Description

Partnership to launch Cancer Trials Canada, Canada's only bilingual website to enhance awareness and access to cancer clinical trials. The platform provides comprehensive trial information to patients, caregivers, and healthcare providers.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading the LUNA-2 clinical trial, the largest-ever Canadian clinical trial testing FMT combined with immunotherapy for lung cancer, enrolling 160 patients across Canada.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research institute contributing to the LUNA-2 clinical trial with researchers from the London, Ontario facility.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Producing the FMT capsules used in the LUNA-2 trial at their facility, representing a made-in-Canada approach to cancer treatment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with multiple Indigenous organizations to launch Connect to Change, an eight-week Indigenous-led tobacco cessation program offering culturally affirming support through physical activities, nicotine replacement therapy, and helpline follow-up.

12Jesse Marsch
Strategic tierMinorTypeOthers
Description

Head coach of Canada's men's national soccer team serving as ambassador for Soccer for Cancer program. Top fundraising team earns a virtual coaching session with him.

newswire.ca
13Léane Labrèche-Dor
Strategic tierMinorTypeOthers
Description

Actress serving as Lead Ambassador for Quebec, promoting CCS's mission, enhancing public engagement, and supporting fundraising efforts.

newswire.ca
Strategic tierFlagshipTypeGTM or Marketing Partner
Description

CIBC is designated as a Visionary Partner of the Canadian Cancer Society, providing significant corporate sponsorship and support.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Featured corporate partner supporting people affected by cancer in Canada.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Featured corporate partner supporting cancer patients and survivors in Canada.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Featured corporate partner supporting cancer patients and survivors in Canada.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International research partner collaborating on the UPFront project studying ultra-processed foods and colorectal cancer risk.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

International academic partner contributing to the multi-provincial UPFront research project on diet and cancer risk.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The largest US national cancer charity, funding research, providing patient support, and advocating for cancer-related policy. Direct peer given parallel mandate, scale, and revenue model (donations, events, corporate partnerships) to CCS in a different national market.

TypeDirect peer
Description

The UK's largest cancer charity, funding research, providing information, and running awareness campaigns. Closely comparable to CCS in scope (research funding + patient services + advocacy) and in operating as a national monopoly-like charity within its country.

TypeDirect peer
Description

Australia's peak national non-government cancer control organization, funding research and delivering prevention/support programs. Closely mirrors CCS's integrated model of research funding, patient support, prevention, and advocacy at a national level.

TypeDirect peer
Description

Canadian cancer research funding organization and active co-funding partner with CCS on the $25M national clinical trials program. Directly comparable as a Canadian cancer research grantmaking entity with overlapping researcher communities.

TypeDirect peer
Description

US cancer research charity funding investigator-initiated trials across cancer types, including rare and underserved cancers — overlapping with CCS's recent $25M national clinical trials focus. Comparable in mission and donor-funded research grantmaking model.

TypeDirect peer
Description

Canadian cancer research funder that co-leads the $25M national clinical trials consortium with CCS. Directly comparable as a Canadian peer charity funding investigator-initiated cancer research with similar grantmaking operations.

TypeDirect peer
Description

US/UK charity funding collaborative 'Dream Teams' of researchers across institutions for translational cancer research. Comparable in funding collaborative, multi-institution clinical trials focused on accelerating cures, similar to CCS's national trials consortium.

TypeBroad incumbent
Description

Major Canadian health charity funding cardiovascular and stroke research while delivering patient support and prevention programs. Comparable as a large national Canadian health charity with similar donation, event, and advocacy operating model.

TypeBroad incumbent
Description

One of Canada's largest humanitarian charities with national infrastructure, donor base, and government partnerships. Comparable in operating scale, multi-province infrastructure, and reliance on donations and government funding.

TypeRegional player
Description

Provincial cancer fundraising and research foundation serving British Columbia. Operates in a similar space (cancer research funding + patient support) but is geographically restricted to one Canadian province rather than national.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Canadian Cancer Society

Cancer Charity and Patient Support Servicescancer.ca#

The Canadian Cancer Society, founded in 1938, is Canada's largest national cancer charity, funding research, providing patient support and lodging, delivering cancer information, and advocating for cancer-related public policy across all provinces. It serves patients, caregivers, researchers, donors, and underserved communities through a bilingual nationwide network.

What Canadian Cancer Society does

The Canadian Cancer Society (CCS), founded in 1938 and headquartered in Toronto, is Canada's oldest and largest national cancer charity, registered as charity number 118829803 RR 0001. It operates four interlocking functions: cancer research funding (investing $50.8M in research and innovation in 2024-2025 alone and co-leading a $25M multi-partner clinical trials consortium with the Terry Fox Research Institute, Cancer Research Society, and others); direct patient support services delivered through 12+ regional offices and lodging houses (76,000+ patient nights annually), transportation programs (Wheels of Hope, Air Daffodil, Treatment Transport Fund), and toll-free helplines; cancer information and prevention programs (content covering 100+ cancer types, the It's My Life! youth program, Talk Tobacco Helpline, and the Indigenous-led Connect to Change cessation program); and public-policy advocacy credited with 67 health policy victories. Its service portfolio increasingly includes digital products such as Cancer Trials Canada (a bilingual clinical-trial portal launched with Q-CROC) and AskEllyn, an AI-powered storytelling companion for breast cancer patients.

CCS is a registered nonprofit with no shareholders; its operating budget is funded through individual donations, corporate partnerships (CIBC as Visionary Partner, alongside Desjardins, Kruger Products, and WestJet), planned/legacy giving, community fundraising events (Daffodil Month, Soccer for Cancer), and government/research grants (including over $41M from the Government of Canada for cancer prevention research). It serves five primary stakeholder groups: cancer patients and survivors, caregivers and family members, healthcare professionals, cancer researchers (as grantees), and donors/supporters, with deliberate outreach to Indigenous peoples and underserved communities through equity-focused programs. Headcount is reported in the 5,001-10,000 range, consistent with a national footprint spanning all provinces and operating bilingual (English/French) service delivery.

Technically, CCS is not a technology company; its core platform is a service-delivery and research-funding organization. Its technology footprint centers on the cancer.ca web platform (bilingual), social media channels across six platforms (LinkedIn, Facebook, Instagram, TikTok, YouTube, Bluesky), the Cancer Trials Canada portal, and the AskEllyn AI companion. CCS has begun adopting AI governance frameworks for ethical data use and complies with the CSA Model Code for the Protection of Personal Information (CAN/CSA-Q830-96) and Ontario's AODA (Regulation 191/11). The organization's strategic direction, evidenced by recent launches, is to consolidate its position as Canada's national convener in cancer research, expand digital health tooling, and broaden health-equity reach into Indigenous and underserved populations.

Canadian Cancer Society firmographics

Firmographics
Name
Canadian Cancer Society
Legal name
Canadian Cancer Society
Website
https://cancer.ca#
Company type
Private
Founded year
1938
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
The Canadian Cancer Society, founded in 1938, is Canada's largest national cancer charity, funding research, providing patient support and lodging, delivering cancer information, and advocating for cancer-related public policy across all provinces. It serves patients, caregivers, researchers, donors, and underserved communities through a bilingual nationwide network.
Ownership category
akta.pro rank

Canadian Cancer Society industry classification

Industry
Product category
Cancer Charity and Patient Support Services
NAICS
Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321), Social Advocacy Organizations (8133)
SIC
Services-Social Services (8300), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
akta.pro secondary industries
Health & Medical Research Grantmaking Foundations (BPAGAKAL), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

  • Cancer research funding
  • Cancer support services
  • Patient lodging accommodations
  • Cancer prevention programs
  • Health charity fundraising

Where Canadian Cancer Society is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices13 records

Markets served

Canadian Cancer Society business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Individual Donations: The primary revenue stream comes from individual donors who make personal donations through the CCS website, phone, or mail. Donations support cancer research, patient support services, and advocacy efforts.
  2. Corporate Partnerships and Sponsorships: Corporate partners including CIBC (Visionary Partner), Desjardins, Kruger, and WestJet provide financial support, sponsorships, and in-kind contributions through fundraising events and campaigns.
  3. Daffodil Month Campaign: Annual flagship fundraising campaign held each April, with matching funds available for a portion of the campaign period to accelerate progress and improve survival rates.
  4. Soccer for Cancer Program: National fundraising program enabling soccer players and communities to organize and host cancer fundraising events at community pitches, training facilities, and tournament fields.
  5. Planned and Leadership Giving: Bequests, legacy gifts, and major donor programs for significant contributions supporting long-term cancer research and support initiatives.
  6. Government and Research Grants: CCS partners with government agencies (Government of Canada invested over $41 million in cancer prevention research) and co-funds research initiatives with other foundations.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Canadian Cancer Society product offering

Product offering

Core offering

The Canadian Cancer Society funds cancer research through grants and multi-partner coalitions, delivers nationwide cancer information covering more than 100 cancer types, and operates direct patient support services including lodging houses, volunteer transportation, and tobacco cessation helplines. It also runs national fundraising campaigns (Daffodil Month, Soccer for Cancer) and advocacy programs such as the Pan-Canadian Lung Cancer Action Plan.

Product overview

The Canadian Cancer Society offers a comprehensive portfolio of cancer-related products and services spanning digital platforms, support services, prevention programs, and research initiatives. Key digital offerings include Cancer Trials Canada (a bilingual clinical trial portal), AskEllyn (an AI-powered storytelling companion for breast cancer patients), and the It's My Life! prevention program. Support services include nationwide lodging facilities, transportation programs (Wheels of Hope, Air Daffodil, Treatment Transport Fund), the Talk Tobacco Helpline, and the Connect to Change Indigenous tobacco cessation program. Fundraising initiatives include the annual Daffodil Month campaign and the newly launched Soccer for Cancer program. The Society also drives advocacy through the Pan-Canadian Lung Cancer Action Plan and funds clinical research through partnerships with institutions including the Terry Fox Research Institute.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 18.3 million people supported with cancer information
  • +4 more outcomes

Companies that use Canadian Cancer Society

Customer profile

Segments7 records

Ideal customer profiles5 records

Canadian Cancer Society technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Canadian Cancer Society partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered core, major, minor and flagship.

  • Cancer Research SocietycoreStrategic or Co-development Partner · 22 April 2026$25 million multi-partner investment to support investigator-initiated clinical trials across Canada focused on rare, underserved, and low-survival cancers. Also involves Terry Fox Research Institute and multiple other cancer research funders.
  • Terry Fox Research InstitutecoreStrategic or Co-development Partner · 22 April 2026Partner in $25 million national program to support independent clinical trials for rare, underserved, and low-survival cancers. Brings together major cancer research funders.
  • SickKids Garron Family Cancer CentremajorStrategic or Co-development Partner · 22 April 2026Partner contributing pediatric cancer expertise and research infrastructure to the national clinical trials program.
  • Childhood Cancer CanadamajorStrategic or Co-development Partner · 22 April 2026Partner in the national clinical trials program focused on childhood and adolescent cancers.
  • BioCanRxmajorStrategic or Co-development Partner · 22 April 2026Partner bringing immunotherapy and biotherapeutics expertise to the national clinical trials initiative.
  • Institut du cancer de MontréalmajorStrategic or Co-development Partner · 22 April 2026Partner contributing Montreal-based cancer research expertise to the national clinical trials program.
  • Q-CROC (Quebec – Clinical Research Organization in Cancer)coreStrategic or Co-development Partner · 10 November 2025Partnership to launch Cancer Trials Canada, Canada's only bilingual website to enhance awareness and access to cancer clinical trials. The platform provides comprehensive trial information to patients, caregivers, and healthcare providers.
  • Canadian Cancer Trials Group (CCTG)coreStrategic or Co-development PartnerLeading the LUNA-2 clinical trial, the largest-ever Canadian clinical trial testing FMT combined with immunotherapy for lung cancer, enrolling 160 patients across Canada.
  • London Health Sciences Centre Research InstitutecoreStrategic or Co-development PartnerResearch institute contributing to the LUNA-2 clinical trial with researchers from the London, Ontario facility.
  • Lawson Research InstitutecoreStrategic or Co-development PartnerProducing the FMT capsules used in the LUNA-2 trial at their facility, representing a made-in-Canada approach to cancer treatment.
  • Indigenous Organizations (Prairies)coreStrategic or Co-development PartnerPartnership with multiple Indigenous organizations to launch Connect to Change, an eight-week Indigenous-led tobacco cessation program offering culturally affirming support through physical activities, nicotine replacement therapy, and helpline follow-up.
  • Jesse MarschminorOthersHead coach of Canada's men's national soccer team serving as ambassador for Soccer for Cancer program. Top fundraising team earns a virtual coaching session with him.
  • Léane Labrèche-DorminorOthersActress serving as Lead Ambassador for Quebec, promoting CCS's mission, enhancing public engagement, and supporting fundraising efforts.
  • CIBCflagshipGTM or Marketing PartnerCIBC is designated as a Visionary Partner of the Canadian Cancer Society, providing significant corporate sponsorship and support.
  • DesjardinsmajorGTM or Marketing PartnerFeatured corporate partner supporting people affected by cancer in Canada.
  • Kruger ProductsmajorGTM or Marketing PartnerFeatured corporate partner supporting cancer patients and survivors in Canada.
  • WestJetmajorGTM or Marketing PartnerFeatured corporate partner supporting cancer patients and survivors in Canada.
  • Institut PasteurmajorStrategic or Co-development PartnerInternational research partner collaborating on the UPFront project studying ultra-processed foods and colorectal cancer risk.
  • Université Paris CitémajorStrategic or Co-development PartnerInternational academic partner contributing to the multi-provincial UPFront research project on diet and cancer risk.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Canadian Cancer Society competitors and assessment

Company assessment

Direct peers

  • American Cancer Society: The largest US national cancer charity, funding research, providing patient support, and advocating for cancer-related policy. Direct peer given parallel mandate, scale, and revenue model (donations, events, corporate partnerships) to CCS in a different national market.
  • Cancer Research UK: The UK's largest cancer charity, funding research, providing information, and running awareness campaigns. Closely comparable to CCS in scope (research funding + patient services + advocacy) and in operating as a national monopoly-like charity within its country.
  • Cancer Council Australia: Australia's peak national non-government cancer control organization, funding research and delivering prevention/support programs. Closely mirrors CCS's integrated model of research funding, patient support, prevention, and advocacy at a national level.
  • Terry Fox Research Institute: Canadian cancer research funding organization and active co-funding partner with CCS on the $25M national clinical trials program. Directly comparable as a Canadian cancer research grantmaking entity with overlapping researcher communities.
  • V Foundation for Cancer Research: US cancer research charity funding investigator-initiated trials across cancer types, including rare and underserved cancers — overlapping with CCS's recent $25M national clinical trials focus. Comparable in mission and donor-funded research grantmaking model.
  • Cancer Research Society: Canadian cancer research funder that co-leads the $25M national clinical trials consortium with CCS. Directly comparable as a Canadian peer charity funding investigator-initiated cancer research with similar grantmaking operations.
  • Stand Up To Cancer: US/UK charity funding collaborative 'Dream Teams' of researchers across institutions for translational cancer research. Comparable in funding collaborative, multi-institution clinical trials focused on accelerating cures, similar to CCS's national trials consortium.

Broad incumbents

  • Heart & Stroke Foundation of Canada: Major Canadian health charity funding cardiovascular and stroke research while delivering patient support and prevention programs. Comparable as a large national Canadian health charity with similar donation, event, and advocacy operating model.
  • Canadian Red Cross: One of Canada's largest humanitarian charities with national infrastructure, donor base, and government partnerships. Comparable in operating scale, multi-province infrastructure, and reliance on donations and government funding.

Regional players

  • BC Cancer Foundation: Provincial cancer fundraising and research foundation serving British Columbia. Operates in a similar space (cancer research funding + patient support) but is geographically restricted to one Canadian province rather than national.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Canadian Cancer Society social profiles

Digital presence

Canadian Cancer Society compliance and trust

Trust signal

Compliance2 records

Canadian Cancer Society financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Canadian Cancer Society leadership team

Management profile

Number of profiles

Profiles1 record

Canadian Cancer Society funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Canadian Cancer Society M&A and investment

M&A and investment

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Cancer Society

What does Canadian Cancer Society do?

The Canadian Cancer Society funds cancer research through grants and multi-partner coalitions, delivers nationwide cancer information covering more than 100 cancer types, and operates direct patient support services including lodging houses, volunteer transportation, and tobacco cessation helplines. It also runs national fundraising campaigns (Daffodil Month, Soccer for Cancer) and advocacy programs such as the Pan-Canadian Lung Cancer Action Plan.

Is Canadian Cancer Society a public or private company?

Canadian Cancer Society is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Canadian Cancer Society founded?

Canadian Cancer Society was founded in 1938. It employs 5,001 to 10,000 people.

Where is Canadian Cancer Society based?

Canadian Cancer Society is headquartered in Toronto, Canada, in the North America region.

How does Canadian Cancer Society make money?

Six revenue lines are on record. Individual Donations are the primary driver. The others are corporate Partnerships and Sponsorships, daffodil Month Campaign, soccer for Cancer Program, planned and Leadership Giving and government and Research Grants.

Who are Canadian Cancer Society's main competitors?

Direct peers on record are American Cancer Society, Cancer Research UK, Cancer Council Australia, Terry Fox Research Institute, V Foundation for Cancer Research, Cancer Research Society and Stand Up To Cancer. Broad incumbents are Heart & Stroke Foundation of Canada and Canadian Red Cross. BC Cancer Foundation is listed as a regional player.

Does Canadian Cancer Society have an API?

No public API is recorded for Canadian Cancer Society.

What industry is Canadian Cancer Society in?

Canadian Cancer Society's product category is Cancer Charity and Patient Support Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Financial PostMedia Advisory: Canadian Cancer Society available for comment as Health Ministers meet in Winnipeg to negotiate the Canada Health TransferThe Canadian Cancer Society will comment on Health Ministers' October 15-16, 2026, CHT negotiations, urging dedicated cancer funding. It cites rising cancer cases and deaths, and calls for a 1% CHT increase of about $575 million annually.Financial PostTeam CIBC raises $2.81 million for the 35th Canadian Cancer Society CIBC Run for the CureTeam CIBC raised $2.81 million for the 35th Canadian Cancer Society CIBC Run for the Cure, held on October 4. The event saw over 65,000 participants, with Team CIBC contributing $2.81 million toward breast cancer research and support. CIBC has raised $70.4 million over 30 years as title partner.Financial PostCanadian Cancer Society CIBC Run for the Cure raises $18 million at 35th annual eventThe Canadian Cancer Society CIBC Run for the Cure raised $18 million at its 35th annual event, with over 65,000 participants across 50 communities. The event has raised $558 million for breast cancer research, clinical trials, and support programs. CIBC celebrated 30 years as title sponsor.EIN PresswirePillar of Hope Initiative Turns Every Home Inspection into an Opportunity to Give BackPillar To Post Home Inspectors launched its Pillar of Hope initiative, donating proceeds from home inspections to National Breast Cancer Foundation and Canadian Cancer Society. In 2025, over 120 franchise owners joined, raising nearly $20,000. The campaign aims to raise awareness and support families affected by breast cancer.CBCCanada is rolling out new graphic image warnings on cigarette packs | CBC NewsCanada is implementing new graphic image warnings on cigarette packages, required by August 1, featuring 13 disturbing health images including mouth cancer, bloody urine, and infant smoke exposure, along with messages printed directly on individual cigarettes. Experts from the Canadian Cancer Society and University of Waterloo have endorsed the measure, citing research showing graphic warnings significantly increase smoking cessation efforts and reduce tobacco uptake. The federal government aims to reduce tobacco use to less than 5% by 2035, noting approximately 48,000 Canadians die annually from tobacco-related diseases.Global NewsCanadian health experts call for warnings on alcohol packaging - WinnipegCanadian health experts from the Canadian Cancer Society and Canadian Public Health Association are advocating for warning labels on alcohol packaging similar to the graphic warnings required on cigarette packages for over 25 years. A bill currently before the Canadian Senate proposes adding text warnings to all alcoholic drink packaging, with experts arguing this measure could reduce alcohol consumption and related health harms. A study conducted in the Yukon found that bottles with health warnings and standard drink counts saw a 6.6% decline in sales and self-reported reduced drinking among consumers.WikipediaReynolds Secondary School: Difference between revisionsReynolds Secondary School is a public secondary school located in Saanich, British Columbia, Canada, offering various specialized academic and extracurricular programs. The institution actively supports the Cops for Cancer fundraiser for the Canadian Cancer Society through student-led initiatives such as car washes and bake sales. Since 2010, the school community has raised over $1 million for this charitable cause.NewswireCanadian Cancer Society celebrates national milestone as all provinces enact job-protected leaveThe Canadian Cancer Society celebrated a legislative milestone as New Brunswick granted Royal Assent to job-protected leave for serious illness, making this protection available in every Canadian province. This achievement follows years of advocacy and aligns with the federal extension of Employment Insurance sickness benefits to 26 weeks, aiming to reduce financial hardship for patients. The organization plans to continue working with territorial governments to extend similar protections.Global NewsUsing cultural connection to quit smoking across the PrairiesThe Canadian Cancer Society has partnered with several organizations to launch Connect to Change, an eight-week Indigenous-led program designed to help Indigenous communities reduce or quit commercial tobacco use. The program offers culturally affirming support through physical activities like harvesting medicines, berry picking, and beading, along with six weeks of nicotine replacement therapy and follow-up support via the Talk Tobacco helpline. Indigenous peoples in Canada use commercial tobacco at significantly higher rates than non-Indigenous adults, with Inuit usage 2.4 times higher, First Nations off reserve 1.9 times higher, and Métis 1.7 times higher.NewswireDaffodil Ball celebrates 30 years of impact, raising $6.76 million for world-leading cancer researchThe Daffodil Ball gala raised $6.76 million for the Canadian Cancer Society, marking its 30th year. The funds support gold nanoparticle research for targeted cancer therapies, including for triple-negative breast cancer and glioblastoma. A new Gold Stream in Cancer Research initiative will accelerate gold-based therapies.